Canada has confirmed its first hantavirus case tied to the MV Hondius cruise ship outbreak. A passenger from British Columbia has tested presumptively positive for the Andes strain, the only hantavirus known to spread between people, although such transmission is rare. The patient is currently in hospital isolation in Victoria. While the test results are not yet final, national lab experts in Winnipeg are reviewing them.
Details of the Canadian Case
According to Reuters, authorities report that the patient's symptoms are mild, and the overall risk to the public remains low. Nevertheless, this marks a turning point in one of the most closely monitored disease incidents of the year. The infected individual is one of four people from British Columbia and Yukon who returned from the cruise and entered isolation on Vancouver Island. Provincial health officer Dr. Bonnie Henry noted that the passenger experienced mild fever and headache before seeking hospital care. His partner tested negative but remains under medical observation, while another person from the same accommodation is hospitalized as a precaution. The fourth exposed traveller is isolating at home with daily health checks.
The Andes Strain: A Rare Concern
What makes this situation particularly unusual is the Andes strain itself. Most hantaviruses spread to humans through contact with infected rodents, particularly their urine and droppings. However, the Andes virus stands out as the only known hantavirus capable of direct person-to-person transmission, though it is not easily contracted. Experts emphasize that close and prolonged contact is required, typically involving shared living spaces or exposure to bodily fluids while the infected person is symptomatic. This characteristic raised significant concerns in the cruise ship environment, prompting an aggressive public health response.
The MV Hondius Outbreak
The MV Hondius, operated by Oceanwide Expeditions, departed from Ushuaia, Argentina, for Antarctica weeks ago. As the ship cruised remote islands, several passengers developed severe respiratory symptoms. Initially considered isolated incidents, the situation escalated when labs in South Africa detected hantavirus in critically ill passengers. Health agencies have now linked at least 11 cases and three deaths to this outbreak. The ship carried nearly 150 people from over 20 countries. As cases emerged, countries launched urgent contact tracing, quarantine, and testing efforts involving returning passengers and their contacts. Protocols were implemented in Britain, France, Canada, Spain, the United States, Australia, and others.
Genetic Sequencing and Transmissibility
France's Pasteur Institute conducted genetic sequencing on the virus, finding that it matched existing South American Andes strains with no new mutations or signs of increased transmissibility. This has been reassuring for scientists concerned about the emergence of a more dangerous variant. The likely source of the virus is believed to be exposure during land trips in South America, particularly in areas where local rodents carry the Andes virus. Passengers reportedly visited parts of Argentina and Chile before boarding the Hondius in Ushuaia. After initial exposure, the virus spread among close contacts aboard the ship.
Global Response and Challenges
As the crisis grew, the ship became isolated. Cape Verde could not handle the evacuation, and the Canary Islands hesitated to allow the Hondius to dock. Eventually, passengers flew home under strict health supervision. Dramatic scenes unfolded, including British military medics parachuting onto Tristan da Cunha to assist a stricken traveller, while others were evacuated to hospitals in Europe, South Africa, and South America.
Health Risks and Monitoring
Despite reassurances, epidemiologists remain vigilant. Hantavirus infections can progress rapidly, with early symptoms resembling the flu, including fever, headache, fatigue, chills, and nausea. In some cases, the disease advances to hantavirus pulmonary syndrome (HPS), which can cause fluid buildup in the lungs, respiratory distress, and heart failure. The fatality rate for severe Andes virus infections has reached 40 to 50 percent in some outbreaks. Symptoms may appear anywhere from one to eight weeks after exposure, which is why some passengers continue to be monitored even after negative test results.
Public Risk Assessment
Experts stress that this outbreak is unlikely to become a global pandemic. The World Health Organization, the European Centre for Disease Prevention and Control, and Canadian health officials all assess the risk as low. Andes virus transmission is limited and far less efficient than that of COVID-19 or influenza. Nevertheless, scientists view this outbreak as a wake-up call regarding how quickly rare diseases can spread in an era of global tourism. Canadian officials continue to monitor exposed individuals and await final lab confirmation for the British Columbia patient.
